Emma Lovie

Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing Structures.

C. de la Fuente-Nunez, D. Mercer, M. D. Torres, 2021, ACS infectious diseases.

Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity

D. Mercer, C. Munro, Vanessa M S Duncan, 2021, Antimicrobial agents and chemotherapy.

Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy

C. de la Fuente-Nunez, D. Mercer, M. D. Torres, 2020, Frontiers in Cellular and Infection Microbiology.

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial

V. Lucidi, G. Devereux, C. Daines, 2020, PloS one.

Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex

D. Mercer, D. O'Neil, D. Fraser-Pitt, 2016, Antimicrobial Agents and Chemotherapy.

Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection

N. Woodford, K. Hopkins, D. Mercer, 2018, Infection and Immunity.

Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection

N. Woodford, K. Hopkins, D. Mercer, 2018 .